Mechanism and regulation of V(D)J repair
Mechanism and regulation of V(D)J repair
批准号:
7864147
负责人:
PATRICIA CORTES
金额:
$32.79万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-06-15 至 2014-05-31
关键词:
AffectAgeAmino AcidsAntibodiesAntigensCellsCleaved cellComplexCryoelectron MicroscopyCrystallizationCytoplasmDNADNA Binding DomainDNA RepairDNA-PKcsDataData SetDefectDevelopmentDiseaseG22P1 geneGelGenesGenetic RecombinationGenome StabilityGenomicsGrowthGrowth and Development functionHumanImmuneImmune systemImmunodeficiency and CancerImmunologic Deficiency SyndromesIn VitroKnowledgeLIG4 geneLigaseLinkLymphocyteLymphoidMediatingMicrocephalyMolecularMutationN-terminalNonhomologous DNA End JoiningPaste substancePathway interactionsPatientsPatternPeptide Signal SequencesPhenotypePlayPost-Translational Protein ProcessingPrincipal InvestigatorProcessPropertyProtein FragmentProteinsRAG1 geneRecombinant ProteinsRegulationRoleSpecificityStem cellsStructureSyndromeT-Cell ReceptorT-LymphocyteV(D)J RecombinationWorkXRCC4 geneartemisbasecomplex IVexhaustionhuman diseasein vivomigrationmutantneural growthnovelprogramsprotein complexprotein protein interactionpublic health relevancerepairedresearch study
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Ligase IV has been shown to play critical roles in Non-Homologous End Joining (NHEJ), V(D)J recombination and development of the immune system, stem cell exhaustion, ageing and neural growth and development, as exemplified by the phenotype of patients with hypomorphic mutations in Ligase IV. Numerous proteins have been shown to modulate Ligase IV activity. Among them, XRCC4 and Cernunnos/XLF are perhaps the best/most conclusively characterized. Both of these factors, like Ligase IV, are part of the core-NHEJ machinery. Human mutations in XRCC4 have not been described yet, but interestingly, Cernunnos/XLF mutations in humans result in growth defects, microcephaly and immunodeficiency, similar to what has been observed for Ligase IV mutations. Our recent findings have identified Artemis, a factor also linked to immunodeficiency in humans, as a protein that directly interacts with Ligase IV, in addition we have observed regulation of XRCC4 by Ligase IV. In this project we propose to analyze the functional relevance of these novel Ligase IV/Artemis complex in genomic stability and V(D)J recombination. The mechanism by which Ligase IV regulates XRCC4 function, and the composition and function of endogenous Ligase IV complexes in lymphocytes will also be investigated. Our preliminary work with Ligase IV recombinant protein and protein fragments has resulted in crystallization of a Ligase IV fragment containing the Ligase IV DNA binding domain. Experiments are proposed to solve the structure of Ligase IV and/or Ligase IV in complex with Artemis. All these are challenging yet very relevant experiments for which we show significant progresses. Furthermore, the impact of mutations identified in patients with LIG4 syndrome on regulation of its function by Artemis and on how these mutant Ligase IV proteins affect XRCC4 function will also be investigated. Information gained from the proposed studies will contribute to a molecular and structural understanding of NHEJ, V(D)J recombination and human diseases linked to defects in both of these processes. PUBLIC HEALTH RELEVANCE: Despite important progress in our understanding of Ligase IV function, its structure remains largely uncharacterized and our preliminary data suggest novel mechanisms of regulation that remain to be unraveled. This project proposes to investigate our preliminary finding on novel Ligase IV interactions and functions by using in vivo and in vitro approaches; we also propose studies to solve the structure of Ligase IV and Ligase IV complexes. By increasing our knowledge of Ligase IV structure, function and regulation, in V(D)J recombination and DNA repair, the proposed work will contribute to our understanding of human disease, specifically, Ligase IV and Artemis mediated, immunodeficiency and cancer and will facilitate the path to find better treatments for this debilitating diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of V(D)J recombination by Rag2 C terminus
-
批准号:8073125
-
项目类别:
-
资助金额:$33.56万
-
财政年份:2010
-
负责人:PATRICIA CORTES
-
依托单位:
Regulation of V(D)J recombination by Rag2 C terminus
-
批准号:7781189
-
项目类别:
-
资助金额:$32.51万
-
财政年份:2010
-
负责人:PATRICIA CORTES
-
依托单位:
Regulation of V(D)J recombination by Rag2 C terminus
-
批准号:8260320
-
项目类别:
-
资助金额:$33.56万
-
财政年份:2010
-
负责人:PATRICIA CORTES
-
依托单位:
Regulation of V(D)J recombination by Rag2 C terminus
-
批准号:8653520
-
项目类别:
-
资助金额:$33.56万
-
财政年份:2010
-
负责人:PATRICIA CORTES
-
依托单位:
Regulation of V(D)J recombination by Rag2 C terminus
-
批准号:8458581
-
项目类别:
-
资助金额:$31.55万
-
财政年份:2010
-
负责人:PATRICIA CORTES
-
依托单位:
Artemis: Biochemical ,structural and functional analysis
-
批准号:7372935
-
项目类别:
-
资助金额:$41.36万
-
财政年份:2009
-
负责人:PATRICIA CORTES
-
依托单位:
Mechanism and regulation of V(D)J repair
-
批准号:8475536
-
项目类别:
-
资助金额:$30.51万
-
财政年份:2009
-
负责人:PATRICIA CORTES
-
依托单位:
Mechanism and regulation of V(D)J repair
-
批准号:8278683
-
项目类别:
-
资助金额:$32.46万
-
财政年份:2009
-
负责人:PATRICIA CORTES
-
依托单位:
Mechanism and regulation of V(D)J repair
-
批准号:8075422
-
项目类别:
-
资助金额:$32.46万
-
财政年份:2009
-
负责人:PATRICIA CORTES
-
依托单位:
Mechanism and regulation of V(D)J repair
-
批准号:7727628
-
项目类别:
-
资助金额:$31.73万
-
财政年份:2009
-
负责人:PATRICIA CORTES
-
依托单位:
Artemis: Biochemical ,structural and functional analysis
-
批准号:7896656
-
项目类别:
-
资助金额:$42.05万
-
财政年份:2009
-
负责人:PATRICIA CORTES
-
依托单位:
Artemis: Biochemical, structural and functional analysis
-
批准号:7432255
-
项目类别:
-
资助金额:$42.38万
-
财政年份:2007
-
负责人:PATRICIA CORTES
-
依托单位:
Combined Immune Deficiency: Links to Repair Defects
-
批准号:6847368
-
项目类别:
-
资助金额:$16.35万
-
财政年份:2004
-
负责人:PATRICIA CORTES
-
依托单位:
MECHANISM OF CODING JOINT FORMATION
-
批准号:6374261
-
项目类别:
-
资助金额:$27.88万
-
财政年份:1999
-
负责人:PATRICIA CORTES
-
依托单位:
MECHANISM OF CODING JOINT FORMATION
-
批准号:6642033
-
项目类别:
-
资助金额:$29.36万
-
财政年份:1999
-
负责人:PATRICIA CORTES
-
依托单位:
MECHANISM OF CODING JOINT FORMATION
-
批准号:2911334
-
项目类别:
-
资助金额:$3.43万
-
财政年份:1999
-
负责人:PATRICIA CORTES
-
依托单位:
MECHANISM OF CODING JOINT FORMATION
-
批准号:6200791
-
项目类别:
-
资助金额:$22.31万
-
财政年份:1999
-
负责人:PATRICIA CORTES
-
依托单位:
MECHANISM OF CODING JOINT FORMATION
-
批准号:6532796
-
项目类别:
-
资助金额:$29.41万
-
财政年份:1999
-
负责人:PATRICIA CORTES
-
依托单位:
MECHANISM OF CODING JOINT FORMATION
-
批准号:6170622
-
项目类别:
-
资助金额:$27.96万
-
财政年份:1999
-
负责人:PATRICIA CORTES
-
依托单位:
Combined Immune Deficiency: Links to Repair Defects
-
批准号:7367086
-
项目类别:
-
资助金额:$31.32万
-
财政年份:--
-
负责人:PATRICIA CORTES
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: